Compare Gilead Sciences, Inc. (GILD) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Roblox Corp — how do they compare? Gilead Sciences, Inc. trades at $151.17 (market cap $182.40B), while Roblox Corp trades at $48.09 (market cap $32.52B). The key difference: Gilead Sciences, Inc. is far larger — about 5.6× Roblox Corp's market cap, and Gilead Sciences, Inc. pays a 2.23% dividend while Roblox Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gilead Sciences, Inc. for 111 Days and Roblox Corp for 93 Days on average.
| GILD | RBLX | |
|---|---|---|
Market Cap | $182.40B | $32.52B |
Volume | 4,469,821 | 14,552,045 |
Sector | Health | Technology |
52-Week High | $155.80 | $138.56 |
52-Week Low | $117.18 | $35.54 |
Typical Hold Time | 111 Days | 93 Days |
Enterprise Value | $205.46B | $31.34B |
Dividend Yield | 2.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $147.10, up 0.17% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings have mostly beaten expectations, though Q2 2026 saw a significant loss. The company maintains robust operating cash flow and has expanded access to its HIV prevention drug lenacapavir in Latin America, signaling growth potential in its core franchises.
The outlook is positive given analyst buy ratings and a $151.57 price target, but risks include negative net income margin and ROE in 2026, high debt levels, and reliance on pipeline success. The stock offers value if HIV and oncology advances materialize, yet investors face volatility from earnings inconsistencies and competitive pressures.
Roblox (RBLX) trades at $45.53, down 1.9% on the day, with a bearish technical signal and mixed analyst sentiment. The company shows strong revenue growth, reaching $4.89B in 2025, but remains unprofitable with a net loss of $1.07B. Recent news includes a Jefferies downgrade to Underperform citing concerns about bookings growth, though the stock has beaten EPS estimates in recent quarters. Cash flow from operations improved to $1.8B in 2025, supporting ongoing investments.
The outlook for RBLX hinges on balancing rapid revenue expansion with a path to profitability. Investment opportunities include its growing user base and AI-driven creator tools, but risks include persistent losses, high valuation multiples (P/S 5.67), and competitive pressures. Wall Street consensus is mixed with a $50.85 price target, suggesting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
